Evaluation of risk for incident hypertension using glomerular filtration rate in the normotensive general population

Journal of Hypertension

Volumn 30, Issue 3, 2012, Pages 505-512

  Takase, Hiroyuki ^a   Dohi, Yasuaki ^b   Toriyama, Takayuki ^a   Okado, Tateo ^a   Tanaka, Satoru ^b   Sonoda, Hiroo ^b   Kimura, Genjiro ^b  

^a Enshu Hospital   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

blood pressure; cohort; glomerular filtration rate; hypertension; kidney; proteinuria

Indexed keywords

ADULT; AGED; BLOOD PRESSURE; CARDIOVASCULAR RISK; CONFERENCE PAPER; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; POPULATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

EID: 84857060376     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834f6a1d     Document Type: Conference Paper

References (35)

1. Japanese Society of Hypertension. Japanese Society of Hypertension Guidelines for the management of hypertension (JSH 2004). Hypertens Res 2006; 29(Suppl):S1-S105.
2. Sairenchi T, Iso H, Irie F, Fukasawa N, Yamagishi K, Kanashiki M, et al. Age-specific relationship between blood pressure and the risk of total and cardiovascular mortality in Japanese men and women. Hypertens Res 2005; 28:901-909. (Pubitemid 43173960)
3. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 289:2560-2571.
4. Kannel WB. Hypertension as a risk factor for cardiac events: epidemiologic results of long-term studies. J Cardiovasc Pharmacol 1993; 21:S27-S37. (Pubitemid 23225170)
5. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 1997; 277:1624-1632.
6. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, et al. Trial of Preventing Hypertension (TROPHY) Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354:1685-1697.
7. Tissot AC, Maurer P, Nussberger J, Sabat R, Pfister T, Ignatenko S, et al. Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebocontrolled phase IIa study. Lancet 2008; 371:821-827. (Pubitemid 351323893)
8. Cowley AW Jr, Skelton MM, Papanek PE, Greene AS. Hypertension induced by high salt intake in absence of volume retention in reduced renal mass rats. Am J Physiol 1994; 267:H1707-H1712. (Pubitemid 24363715)
9. Campese VM. Neurogenic factors and hypertension in renal disease. Kidney Int Suppl 2000; 75:S2-S6. (Pubitemid 30205432)
10. Fukuda M, Munemura M, Usami T, Nakao N, Takeuchi O, Kamiya Y, et al. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy. Kidney Int 2004; 65:621-625. (Pubitemid 38130657)
11. Kimura G. Glomerular function reserve and sodium sensitivity. Clin Exp Nephrol 2005; 9:102-113. (Pubitemid 40875098)
12. Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, et al. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 2006; 47:42-50. (Pubitemid 41828265)
13. Kimura G, Dohi Y, Fukuda M. Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events. Hypertens Res 2010; 33:515-520.
14. Preston RA, Singer I, Epstein M. Renal parenchymal hypertension: current concepts of pathogenesis and management. Arch Intern Med 1996; 156:602-611. (Pubitemid 126510076)
15. Buckalew VM Jr, Berg RL, Wang SR, Porush JG, Rauch S, Schulman G. Prevalence of hypertension in 1 795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis 1996; 28:811-821. (Pubitemid 26412076)
16. CowleyAWJr, Roman RJ. The role of the kidney in hypertension. JAMA 1996; 275:1581-1589. (Pubitemid 126570086)
17. Andoh TF, Johnson RJ, Lam T, Bennett WM. Subclinical renal injury induced by transient cyclosporine exposure is associated with saltsensitive hypertension. Am J Transplant 2001; 1:222-227. (Pubitemid 33674165)
18. Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D'Agostino RB, et al. Lowgrade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005; 111:1370-1376. (Pubitemid 40396802)
19. Wang TJ, Gona P, Larson MG, Levy D, Benjamin EJ, Tofler GH, et al. Multiple biomarkers and the risk of incident hypertension. Hypertension 2007; 49:432-438.
20. Forman JP, Fisher ND, Schopick EL, Curhan GC. Higher levels of albuminuria within the normal range predict incident hypertension. J Am Soc Nephrol 2008; 19:1983-1988.
21. Kestenbaum B, Rudser KD, de Boer IH, Peralta CA, Fried LF, Shlipak MG, et al. Differences in kidney function and incident hypertension: the multiethnic study of atherosclerosis. Ann Intern Med 2008; 148:501-508. (Pubitemid 351665418)
22. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53:982-992.
23. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298:2038-2047. (Pubitemid 350074801)
24. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287:1003-1010. (Pubitemid 34252058)
25. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187. (Pubitemid 46924065)
26. Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D. C-reactive protein is associated with renal function abnormalities in a nondiabetic population. Kidney Int 2003; 63:654-661. (Pubitemid 36126812)
27. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1988; 1:335-347.
28. Law CM, de Swiet M, Osmond C, Fayers PM, Barker DJ, Cruddas AM, Fall CH. Initiation of hypertension in utero and its amplification throughout life. BMJ 1993; 306:24-27. (Pubitemid 23004943)
29. Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 1994; 23:171-175. (Pubitemid 24075306)
30. Curhan GC, Chertow GM, Willett WC, Spiegelman D, Colditz GA, Manson JE, et al. Birth weight and adult hypertension and obesity in women. Circulation 1996; 94:1310-1315. (Pubitemid 26307258)
31. Luyckx VA, Brenner BM. Low birth weight, nephron number, and kidney disease. Kidney Int Suppl 2005; 97:S68-S77.
32. Kojima M, Dohi Y, Ohashi M, Sato K, Kimura G. Crucial role of kidney function in resistance to antihypertensive therapy in patients with diabetes mellitus. J Hypertens 2010; 28:2323-2328.
33. Watson RD, Lumb R, Young MA, Stallard TJ, Davies P, Littler WA. Variation in cuff blood pressure in untreated outpatients with mild hypertension- implications for initiating antihypertensive treatment. J Hypertens 1987; 5:207-211. (Pubitemid 17092346)
34. Sega R, Cesana G, Bombelli M, Grassi G, Stella ML, Zanchetti A, Mancia G. Seasonal variations in home and ambulatory blood pressure in the PAMELA population. Pressione Arteriose Monitorate E Loro Associazioni. J Hypertens 1998; 16:1585-1592. (Pubitemid 28515484)
35. Modesti PA, Morabito M, Bertolozzi I, Massetti L, Panci G, Lumachi C, et al. Weather-related changes in 24-h blood pressure profile: effects of age and implications for hypertension management. Hypertension 2006; 47:155-161. (Pubitemid 43189757)